Inside the Current Issue

Cover Story
Managing critical care supply tensions
Self Study Series
Purchasing Connection
Resources
Show Calendar
HPN Hall of Fame
HPN ProductLink
Classifieds
Issue Archives
Advertise
About Us
Home
Subscribe

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Email Newsletter

For Email Marketing you can trust
Special Event Photos
Contact Us
KSR Publishing, Inc.
Copyright © 2012

People, Places, Processes & Products that Influence the Supply Chain

 

INSIDE THE CURRENT ISSUE

September 2009

Infection Protection

Championing change for VAP prevention

by Robyn Whalen

Hearing first-hand from clinicians who have successfully developed and implemented practices that have reduced many of the risks associated with ventilator-associated pneumonia (VAP) makes what I do everyday worthwhile. It’s what brings meaning to the countless hours spent on devising ways to communicate not only the clinical features and benefits of the products that we offer, but more important, the essence of how our products help to enable the very noble patient safety goals upheld by very capable medical teams. Recently, I had an opportunity to sit down with respiratory therapist Mike Hewitt and hear his remarkable story of championing change within his facility. I hope that it inspires you as much as it did me.

Many clinicians and hospital administrators today are anxiously awaiting enactment of CMS "Never Event" regulations governing VAP before they begin planning and incorporating new VAP prevention programs within their facilities. Uneasiness about policy changes that could challenge familiar and long-standing practices can often be a barrier to change, even when it’s evident that change is necessary.

But for Michael Hewitt, RRT-NPS, FAARC, FCCM, director of respiratory, pulmonary, sleep and neurology at Peninsula Regional Medical Center in Salisbury, MD, potential CMS rulings were not a factor back in 2006 when he decided to implement VAP Prevention "Best Practices" within his ICU.

At that time, Hewitt was serving as director of respiratory care and pulmonary diagnostics at a large trauma center in the Southwest U.S. when he became concerned about the rising number of VAP cases and bounce backs to his facility’s intensive care units. Knowing that reducing VAP rates was not only possible, but obligatory, Hewitt took a proactive stance by aggressively augmenting the VAP prevention bundle program recommended by many healthcare organizations such as the CDC, AACN, APIC and others that his facility already had in place.

Shared commitment to success

To ward off VAP before conditions worsened, Hewitt and his respiratory staff began treating vented patients as if they were all at-risk for acquiring VAP. By increasing sigh breathing and vibratory therapy, his ultimate goal was to wean and keep his patients off their ventilators as quickly as possible.

But for those patients required to maintain mechanical ventilation, Hewitt was faced with overcoming the challenge of transforming an organizational culture identified by individualized and sometimes conflicting routines deep-rooted in traditional practices and personal habits. Fortunately, Hewitt was able to obtain support to move forward with his approach from top management, and by his team leading through example, a cultural transformation within the organization began to occur as old habits and behaviors began to be replaced by VAP Prevention "best practices".

Hewitt knew patients depended upon a collaborative sense of consistency and accountability shared among each caregiver responsible for providing patient care, and only through integrating standard VAP preventative "best practices" within their daily routines, would VAP rates began to decrease. From increasing personal hand-washing frequency, to conducting early VAP diagnosis, to providing consistent comprehensive oral care among patients, each caregiver was responsible for tracking and monitoring these and other VAP preventative measures, ensuring protocol standards were met and adhered.

Additional best practices

To decrease the opportunity for infection, cross-contamination and alveolar derecruitment, Hewitt stresses the importance of using closed suction catheter systems when clearing a patient’s airway. In addition, early and consistent diagnosis of VAP for nonbronchoscopic bronchoalveolar lavage is an underutilized, but major tool in the fight against VAP. A procedure that can be conducted by trained respiratory therapists, the catheter extends deeper into the lungs for a sample that can help determine if any specific organism is present, allowing for more accurate antibiotic coverage. Along with other VAP preventative measures, an aggressive and comprehensive oral care program must be in place, to prevent the aspiration of oropharangeal pathogens into the lungs.

Results

The results on patient outcomes were significant. Bounce back rates to the ICU were decreased from 3-4 percent to almost zero; length of stay, cost of care, and overall mortality rates were all decreased. In fact, during the 18-month period since he and his staff took a proactive stance against VAP, rates were reduced by 48 percent.

Future success: Insights and ‘lessons learned’

Since recently becoming the director of respiratory, pulmonary and neurology at Peninsula Regional Medical Center, Hewitt is enthused about the successes he and his staff have already experienced by implementing many of the "lessons learned" he gained while at Memorial Hermann.

Revealing a passion and sense of responsibility for his patient’s well-being, Hewitt emphasized the most important improvement a caregiver can make in the prevention of VAP, is frequent hand washing. Although a simple task, Hewitt acknowledges that washing ones hands both before and after every patient contact is not always easy to remember, but incorporating this personal habit is a vital practice all caregivers and hospital staff must strive to achieve.

Robyn Whalen is marketing director of North America Medical Devices for Kimberly-Clark Health Care.

Mike Hewitt’s checklist for implementing VAP-prevention best practices

1) All ICU patients shall be assessed upon admission, PRN and before discharge out of the ICU by the ICU therapists. Included in their assessment will be a current chest x-ray, cough ability and quality, oxygenation, secretions and patient mobility. A transfer report must be called to the receiving therapist on all patients leaving the ICU by the ICU therapist.

2) Patients who have atelectasis and/or consolidation shall be placed "bad" lung up to facilitate expansion and mobilization of secretions in the affected lung during delivery of their respiratory treatments.

3) Patients with a bilateral process shall be positioned appropriately positions as determined by the RT during their therapy.

4) Perform deep breathing and coughing therapy.

5) Evaluate trach suctioning every 4 hours (q4) & PRN.

6) Reassess patients every 72 hours to determine appropriateness of current therapies.

7) At these 72-hour intervals, the therapy must be discontinued, modified, or reordered as is. The therapy may be modified before the 72-hour mandatory assessment period when indicated for changes in status. Appropriate documentation is required and will support whichever course of action is taken.

8) Assessments shall be performed between the mandatory 72 hour assessments as appropriate for monitoring the patient’s status.

9) Changes to therapy must be communicated to the primary team and the notification documented, including the name of the party notified.

Patient Entry Criteria to ICU:

• Post operative laparotomy or thoracotomy

• 2 or more rib fractures

• Prolonged bed rest (anticipated 3 days)

• Chest tube in place

• Pre-existing airway disease

• Age ( 65 years)

• Any patient with IS d" 15 cc/kg/IBW

Patients shall remain on q4 therapy for as long as they meet any aspect of the entry criteria listed above. For patients that are e" 65 years of age, at least one additional component of the entry criteria must be met to continue q4 therapy.

Exiting Criteria from ICU:

• > 5 days post operative laparotomy or thoracotomy with none of the entry criteria present

• Patient freely mobile

• IS ≥ 15 cc/kg/IBW x 24 hours

• No active respiratory process

• No other evident factors placing the patient at risk for pulmonary complications

72 hours post ICU discharge and absence of active or evident pulmonary complication

Once a patient meets the exit criteria, their treatments shall be changed to PRN and they shall receive a pulmonary assessment q12 until discharge. This assessment shall be documented.